Tuesday, July 21, 2015

Novartis Can Sell Copycat of Amgen's Neupogen in September

A U.S. appeals court said Novartis AG could begin selling the first knockoff of a biotech drug on Sept. 2, a key step in efforts to contain spending on high-cost therapies through lower-priced competition.

from WSJ.com: US Business http://ift.tt/1VqYRhv
via IFTTT

No comments:

Post a Comment